COPD Research has 476 eligible papers in the latest 30-day evidence window, up 15% from the prior window, with representative work spanning Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease; Smoking and mortality risk in COPD patients: a prospective cohort study in Sichuan, China; and COPD Patients with a High Exacerbation Risk: Baseline Data Analysis of a National Chinese Prospective Multi-Center Study of Quality Improvement Project.
COPD Research shows 476 eligible recent papers and 476 commentary-ready papers in the current 30-day window, compared with 415 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers.
COPD Research recorded 476 eligible papers in the latest 30-day window, compared with 415 in the prior 30-day window, making the current snapshot up 15% from the prior window.
476 recent vs 415 prior eligible papersChronic Obstructive Pulmonary Disease (COPD) Research contributes 476 eligible recent papers, including 476 papers with abstracts available for commentary.
476 papers in the leading clusterThe representative set includes Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease; Smoking and mortality risk in COPD patients: a prospective cohort study in Sichuan, China; COPD Patients with a High Exacerbation Risk: Baseline Data Analysis of a National Chinese Prospective Multi-Center Study of Quality Improvement Project; Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials; and Mechanisms of dyspnoea and exercise intolerance in smokers with preserved ratio impaired spirometry. These papers anchor the page's claims and keep the brief tied to visible evidence.
8 representative papersChronic Obstructive Pulmonary Disease (COPD) Research accounts for 476 eligible recent papers, including 476 commentary-ready papers in this evidence window.
476 recent eligible papersThe selected papers cover Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease; Smoking and mortality risk in COPD patients: a prospective cohort study in Sichuan, China; COPD Patients with a High Exacerbation Risk: Baseline Data Analysis of a National Chinese Prospective Multi-Center Study of Quality Improvement Project; and Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials.
8 representative papersA recent paper from Frontiers in Pharmacology in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Frontiers in Medicine in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from International Journal of COPD in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from American Journal of Respiratory and Critical Care Medicine in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from European Journal of Applied Physiology in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from BMC Pulmonary Medicine in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Frontiers in Medicine in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from European Respiratory Journal in the Chronic Obstructive Pulmonary Disease (COPD) Research evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.